ESMO26: Vincent Xu, MD on KIM1 in Kidney Cancer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ESMO26: Vincent Xu, MD on KIM1 in Kidney Cancer

  • November 17, 2026

Share

  • 1

    Vincent (Wenxin) Xu, MD, discussed KIM-1 in advanced kidney cancer.

  • 2

    The report focused on patients with advanced kidney cancer receiving immunotherapy alone.

  • 3

    KIM-1 reductions were observed in immune-inflamed tumors.

  • 4

    No KIM-1 drop was linked to immune-depleted tumors.

  • 5

    The context does not provide further study details or outcomes.

Original Source(s)

Related Content